SCHIZOAFFECTIVE DISORDER
Clinical trials for SCHIZOAFFECTIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new SCHIZOAFFECTIVE DISORDER trials appear
Sign up with your email to follow new studies for SCHIZOAFFECTIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Eye scan could reveal best drug for schizophrenia
Disease control TerminatedThis study tested whether a non-invasive scan of the eye's blood vessels could predict which patients with early schizophrenia would respond to an intravenous drug called sodium nitroprusside. The drug was given to help reduce symptoms of psychosis and improve thinking. The goal …
Matched conditions: SCHIZOAFFECTIVE DISORDER
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Apr 02, 2026 01:11 UTC
-
Study links mental health drugs to heart risk - tests solutions
Disease control TerminatedThis study looked at heart disease risk in people taking medications for schizophrenia, schizoaffective disorder, or bipolar disorder. Researchers measured blood fats and heart electrical patterns to identify those at highest risk. They then tested whether changing medications, i…
Matched conditions: SCHIZOAFFECTIVE DISORDER
Phase: PHASE3 • Sponsor: Northwestern University • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Online hub tested to help young adults with psychosis feel less alone
Knowledge-focused TerminatedThis study looked at how well a digital platform called Horyzons could be added to regular mental health care. Horyzons offers therapy content and a private social network. Researchers worked with clinics in North Carolina to understand what helps or hinders using the platform. T…
Matched conditions: SCHIZOAFFECTIVE DISORDER
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC